Short Wave - These bacteria may be key to the fight against antibiotic resistance

Episode Date: February 9, 2026

In 1928, a chance contaminant in Scottish physician Alexander Fleming’s lab experiment led to a discovery that would change the field of medicine forever: penicillin. Since then, penicillin and other antibiotics have saved millions of lives. With one problem: the growing threat of antibiotic resistance. Today on Short Wave, host Regina G. Barber talks to biophysicist Nathalie Balaban from Hebrew University about the conundrum — and a discovery her lab has made in bacteria that could turn the tides.Check out our episodes on extreme bacteria in Yellowstone and the last universal common ancestor. Interested in more science behind our medicines? Email us your question at [e-mail] to every episode of Short Wave sponsor-free and support our work at NPR by signing up for Short Wave+ at plus.npr.org/shortwave.This episode was produced by Berly McCoy, edited by our showrunner Rebecca Ramirez and fact checked by Tyler Jones. Jimmy Keeley was the audio engineer. See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.NPR Privacy Policy

You're listening to Shortwave. From NPR. In 1928, the Scottish physician, Alexander Fleming, made a discovery that would change the field of medicine forever. He was studying bacteria on auger plates in the lab when he noticed something odd. There weren't any bacteria growing around a spot of mold that had contaminated a part of the plate. It turns out, he discovered a medical supercompound, penicillin. Since then, penicillin and other antibiotics have saved millions of lives, with one problem.

The growing threat of antibiotic resistance. Antibiotic resistance means that somehow the bacterium usually acquired a mutation. For example, the penicillin is there, but it doesn't do its job, and therefore the bacterium grows happily and it's resistant to penicillin. This is Natalie Balabon, a biophysicist at the Hebrew University in Jerusalem, And she says more and more bacteria are becoming resistant to all of our antibiotics, which could spell a major problem. One day, all of our antibiotics could stop working,

unless scientists can find a major weakness in bacteria. Recently, Natalie's lab may have done just that by hacking dormant bacteria, because antibiotics, they work by killing off growing bacteria. But sometimes bacteria don't grow. They shut down. And in that case, antibiotics like our guy penicillin are rendered useless. The penicillin will kill all the growing ones, but the one that are not growing are going to persist.

And this is what is it called persistence. Today on the show, antibiotic persistence, what it is and how it can help scientists discover new ways to combat a growing bacterial threat. I'm Regina Barber. You're listening to Shortwave, the science podcast from NPR. Okay, Natalie, antibiotic resistance is definitely a problem. We talked about that, but there's another way bacteria evade antibiotics, which is what you study, right? Like, what is that term? Right. So we study antibiotic persistence, and it's different from resistance because persistor bacteria, they just survive. during the antibiotic treatment. Because they turn onto a dormant form,

they just arrest their growth. And when bacteria arrest their growth, then many antibiotics don't work because antibiotics typically need active growth in order to kill the bacteria. And then those dormant bacteria can come back once the antibiotic is gone. These are the persistors.

So it seems like this dormancy is the key. What did scientists know about this dormant state before you looked into this? So it was known for a long time that when bacteria do not grow, they are not targeted by many antibiotics. They protect themselves from all kinds of stresses. So usually when you starve them, they arrest their growth and then they go into this dormant protected form. But it was not realize that these dormant forms, once they grow again, they can really lead to the speed off of the evolution of antibiotic resistance. When we were prepping for this episode, our team learned that clinicians really don't look at persistence in people. They just kind of focus on

resistance. So definitely resistance is a major problem. And usually if you have a good immune system and you are given the correct antibiotics, these persister bacteria, they are there, but your system is the one that is going to take care of them. So the antibiotics never kill all the bacteria, this we already know, but it's enough in a healthy patient, it's enough for the antibiotic to kill most of the bacteria or even just to arrest the growth of bacteria. But of course, in immunocompromised persons or in a part of the body where the immune system does work or in elderly patient, persistence leads to resistance. And these resistant strains actually can go and infect other people.

Antibiotic persistence can lead to antibiotic resistance. Yes, actually, we saw that when bacteria are more persistent, they have a higher probability of becoming at the end of the day resistant. So in other words, persistence, antibiotic persistence is really a stepping stone for antibiotic resistance. And it means that any new drug that you put on the market, if you are not taking care of so of the persistent bacteria, then they will eventually evolve to be resistant to this drug.

and then this drug will not be as effective as it was. And you published a paper this year in 2026 about how these bacteria can persist in this dormancy state to then become resistant to antibiotics. What did you find in that study? What we found is something that changed the way we look at dormancy. So in the lab, we can use, for example, these antibiotics that just arrest the bacteria.

You can also use all kind of heat stress or pH stress, so there are different stresses, and will create bacteria, will make them enter a state of gross arrest or domency that protects them from different types of antibiotics. Many, many times, form. It was more, you know, you haven't parked your car, and this is why your car is not on the road, it's just, you know, by accident. You just, you had a car crash, and now your car is not moving.

It's not because you're actually stopped because you wanted to. Exactly. This car crash didn't kill them, but it made them stop the growth. Wow. And now this crash, instead of being bad for this bacteria, turned out to be beneficial because now the antibiotics comes, and they happen to be non-growing, and therefore they happen to survive the antibiotic treatment.

So what would be like an example of a car crash in this situation? So in the body, it can be a meeting with an immune cell that is trying to kill the bacteria but doesn't succeed, right? Then I would go into this arrest. They're just putting them in dormant states. They're putting them in dormant state, but what we find out in the lab is that it's not an organized dormant state. It's this car crash type of dormant state. What does it mean for bacteria to be in this more chaotic dormant state? state, like, how does that change how they behave or respond?

So when they're in this chaotic state, instead of being, you know, this bacteria that when you, when they see an external signal, they, they have a very organized response. Now they are trapped into this state that they didn't plan to enter. And it means that now their recovery is going to be very, very long, extremely long, In the context of infection, it means that if you had a persisto bacteria that was in this chaotic state, now you stop the antibiotics. You may not see anything, but after a day or a few days, this chaotic bacteria will start growing again, and then you'll have a reinfection. So the chaos that is governing the recovery time of this bacteria, is also actually dictating how long the treatment should be

because, you know, you need to keep the treatment on for as long as they are in this chaotic state. Yeah. How could knowing this chaotic, this like dysregulated state like that it exists, how can it help us with future antibiotic treatment? So it really has changed the way we thought about tackling persistent, because what we find out in this recent work is that their membrane is more permeable. Oh, okay.

This chaotic state. And now they're all kinds of ideas of how to take advantage of this increased membranial permeability to actually use all kinds of compounds that can kill them. How could this like search for these new types of drugs change? the trajectory of treating antibiotic resistance? So I think it's really realizing that in order to prevent the evolution of resistance, there are many things to do. One of them is to prevent these persistent bacteria from reemerging in these very long infections.

And preventing them from reemerging means treating them with these, probably with this membrane targeting compounds before we stop the antibiotic treatment completely. And then we've treated most of the bacteria. The only one surviving are these chaotic bacteria. Now let's use a compound that is specific against these chaotic bacteria and then stop the treatment. Natalie, thank you so much for talking to me about antibiotic persistence. Thank you.

If you like this episode, listen to our shows on Extreme Bacteria in Yellowstone and The Last Universal Common Ancestor, we'll link to them in our show notes. And follow us on the Empire app or wherever else you get your podcasts. This episode was produced by Burley McCoy and edited by our showrunner Rebecca Ramirez. It was fact-checked by Tyler Jones. Jimmy Keely was the audio engineer. I'm Regina Barber. Thank you for listening to Shortwave from NPR.